Medical Patent News

RSS

USPTO grants patent to Bellacure's drug-free treatment device for arthritis pain

The U.S. Patent and Trademark Office granted a patent today to Bellacure, Inc. for its knee pain treatment device, which was designed to allow the patient to reproducibly apply a therapeutic force that urges the femur and tibia apart on the affected side of the knee at an unmatched intensity level while maximizing force efficiency and minimizing weight (United States Patent 7,662,122).

17 Feb 2010

Soligenix' LPM oral drug delivery technology receives Hong Kong patent

Soligenix, Inc., a late-stage biotechnology company, announced today that it has received a Hong Kong patent which addresses its Lipid Polymer Micelle (LPM™) technology for the improved oral delivery of drugs. The issued Hong Kong patent, HK 1071054, entitled "Stabilized Reverse Micelle Compositions and Uses Thereof" covers lipid structures (reverse micelles) that promote the intestinal absorption of peptides and other sensitive drugs that cannot otherwise be given orally.

17 Feb 2010

ICAP Ocean Tomo offers Medcanica's patent portfolio for sale

ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a patent portfolio relating to a cardiothoracic surgery system owned by Medcanica, LLC. The portfolio consists of 14 U.S. issued patents, 4 non-U.S. patents, and 1 U.S. patent application.

17 Feb 2010

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel. The patent, entitled "Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use," has a priority date of March 4, 2003 and was issued on January 12, 2010.

17 Feb 2010

GeneNews granted second U.S. patent for Sentinel Principle technology

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S. Patent # 7,662,558, entitled "Method of profiling gene expression in a human subject."

17 Feb 2010

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

EKR Therapeutics, Inc., a specialty pharmaceutical company focused on commercializing acute-care hospital products, today announced that the US Patent and Trademark Office has issued two new patents covering methods of treatment and methods of preparation for the Company’s Ready-to-Use (RTU) Cardene® I.V. (nicardipine hydrochloride) Premixed Injection.

17 Feb 2010

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

Teva Pharmaceutical Industries Ltd. today announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with Novartis to settle patent litigation involving Teva’s U.S. generic version of Novartis’ Famvir® (famciclovir) 125 mg, 250 mg and 500 mg tablets including all claims for patent infringement and damages. Teva launched its generic famciclovir tablets in the U.S. in September 2007.

16 Feb 2010

U.S. Court rules in favor of Perrigo over Mucinex patent litigation

Perrigo Company announced today that a federal court has granted summary judgment in its favor in patent litigation involving Guaifenesin Extended-Release Tablets, 600 mg, a generic version of Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, Inc., (a subsidiary of Reckitt Benckiser Group plc.) the New Drug Application holder and patent owner. The United States District Court for the Western District of Michigan ruled today that Perrigo does not infringe the patent in the suit. Perrigo's ANDA is awaiting FDA approval.

12 Feb 2010

European Patent Office affirms validity of EuroMed's patent for Wrinkle-Resistant Wound dressings

EuroMed Inc. and Jentec Inc. today announced an important victory affirming the validity of a key patent, European patent number 1020198 (U.S. corresponding patent number 6878385) for Wrinkle-Resistant Wound dressings. In a ruling issued by the European Patent Office in Berlin, Germany, both of the grounds for opposition raised by the plaintiff, a prominent wound care manufacturer (i.e., extension of subject-matter, lack of ‘inventive step’ or sufficient originality) were not adequate cause to challenge the patent.

12 Feb 2010

Formatech issued patent covering novel formulation methods to enhance solubility of certain hydrophobic compounds

Today, Formatech, Inc. announced the issuance of U.S. patent 7,659,310, entitled “Methods of Enhancing Solubility of Agents” which covers novel formulation methods to enhance the solubility of certain hydrophobic compounds.

12 Feb 2010

Edwards Lifesciences’ German Andersen patent not infringed by Medtronic's CoreValve transcatheter aortic valve system

Medtronic, Inc., announced today that an appeals court in Germany has found that the CoreValve® transcatheter aortic valve system does not infringe Edwards Lifesciences’ German Andersen patent, which is set to expire in May 2011. The appellate court’s decision upholds a lower court’s ruling and enables uninterrupted access to the leading transcatheter heart valve in Germany.

11 Feb 2010

AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA

AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).

10 Feb 2010

Seaside Therapeutics granted U.S patent covering methods of treating autism

Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.

10 Feb 2010

YM BioSciences receives additional AeroLEF patents in U.S.

YM BioSciences Inc., announced that it has been granted two additional patents in the US for AeroLEF(R), the Company's proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe acute pain. US patent numbers 7,648,981 and 7,648,982 extend the life of YM's AeroLEF patent estate in the US to 2024.

10 Feb 2010

USPTO awards Transcept Pharmaceuticals patent covering Intermezzo's composition and usage method

Transcept Pharmaceuticals, Inc. today announced that the first patent covering the composition and method of use of Intermezzo® (zolpidem tartrate sublingual tablet), the lead Transcept product candidate, has been issued by the United States Patent and Trademark Office.

10 Feb 2010

Cynosure settles patent infringement lawsuit against CoolTouch

Cynosure, Inc., developer of the award-winning Smartlipo™ LaserBodySculpting(SM) procedure for minimally invasive removal of fat, and its largest shareholder, El.En. S.p.A, today announced a settlement of their patent infringement lawsuit against CoolTouch, Inc. Cynosure and El.En. alleged that CoolTouch's 1320 nm CoolLipo™ laser system infringed on El.En.'s U.S. Patent No. 6,206,873 (the 873 patent) licensed to Cynosure, which covers laser technology to remove subcutaneous fat.

9 Feb 2010

PriceDoc.com's online healthcare service acquisition and negotiation system awarded U.S. patent

PriceDoc.com, a free, transparent healthcare pricing service and Web site, announced today that the U.S. Patent and Trademark Office issued PriceDoc patent #7,657,479 for its online system of healthcare service acquisition and negotiation, making PriceDoc.com the only online site where patients can "make an offer" for healthcare services with verified providers.

9 Feb 2010

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.

9 Feb 2010

U.S. Court dismisses two of ADI's patent infringement claims against Knowles Electronics

The U.S. District Court in the District of Delaware has ordered the dismissal of two patent infringement claims originally filed by Analog Devices, Inc. (ADI) against Knowles Electronics. The order was issued pursuant to the withdrawal of its claims by Analog Devices under a stipulation of dismissal signed by both parties.

9 Feb 2010

Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTO

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the “Soutschek and Manoharan” patent (Application No. 10/916,185), which covers certain chemically modified siRNAs of any length directed to any target, including siRNAs with sterol conjugates for in vivo delivery.

9 Feb 2010

Medical Patent News

USPTO grants patent to Bellacure's drug-free treatment device for arthritis pain

Soligenix' LPM oral drug delivery technology receives Hong Kong patent

ICAP Ocean Tomo offers Medcanica's patent portfolio for sale

CalciMedica granted U.S. composition patent concerning key component of CRAC channel

GeneNews granted second U.S. patent for Sentinel Principle technology

USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection

Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis

U.S. Court rules in favor of Perrigo over Mucinex patent litigation

European Patent Office affirms validity of EuroMed's patent for Wrinkle-Resistant Wound dressings

Formatech issued patent covering novel formulation methods to enhance solubility of certain hydrophobic compounds

Edwards Lifesciences’ German Andersen patent not infringed by Medtronic's CoreValve transcatheter aortic valve system

AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA

Seaside Therapeutics granted U.S patent covering methods of treating autism

YM BioSciences receives additional AeroLEF patents in U.S.

USPTO awards Transcept Pharmaceuticals patent covering Intermezzo's composition and usage method

Cynosure settles patent infringement lawsuit against CoolTouch

PriceDoc.com's online healthcare service acquisition and negotiation system awarded U.S. patent

USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza

U.S. Court dismisses two of ADI's patent infringement claims against Knowles Electronics

Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTO

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News